Search
Search Results
##search.searchResults.foundPlural##
-
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
183PDF: 210Suppl. Files: 35HTML: 18 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2019PDF: 760HTML: 3113 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1535PDF: 775HTML: 203 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1245PDF: 758HTML: 317 -
The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia
811PDF: 425HTML: 287 -
Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients
1251PDF: 732HTML: 373 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1535PDF: 947HTML: 223 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12348PDF: 1681HTML: 4196Cover letter: 199Figure 1: 204 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1247PDF: 998HTML: 211 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2212PDF: 1497HTML: 267 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2782PDF: 1823HTML: 3668Pellagatti Fig 1: 214Pellagatti Fig. 2: 212 -
-
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1185PDF: 837HTML: 3363 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4068PDF: 1934HTML: 5268Table 1: 191 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7520PDF: 2422HTML: 1733Table 1.: 208Table 2.: 217Table 3.: 202Table 4.: 200 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1969PDF: 753HTML: 696 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1611PDF: 583HTML: 226 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1386PDF: 1308HTML: 100 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1463PDF: 1063HTML: 217 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
851PDF: 1230HTML: 132







